AVIADOBIO LTD

Active London

Research and experimental development on biotechnology

61 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

AVIADOBIO LTD

Research and experimental development on biotechnology

Founded 20 Dec 2019 Active London, England 61 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

NEUROGENEUS LTD 20 Dec 2019 — 2 Dec 2021
Accounts Submitted 31 Jul 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 19 Dec 2025 Next due 2 Jan 2027 8 months remaining
Net assets £31M £8M 2023 year on year
Total assets £34M £9M 2023 year on year
Total Liabilities £4M £594K 2023 year on year
Charges 3
1 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

20 Water Street London E14 5GX England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for AVIADOBIO LTD (12373955), an active life sciences and medical technology company based in London, England. Incorporated 20 Dec 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2020–2023)

Cash in Bank

£28.07M

Increased by £8.76M (+45%)

Net Assets

£30.59M

Increased by £8.13M (+36%)

Total Liabilities

£3.61M

Increased by £593.90k (+20%)

Turnover

N/A

Employees

61

Increased by 23 (+61%)

Debt Ratio

11%

Decreased by 1 (-8%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (9)

Investor NameInvestor SinceParticipating Rounds
Investor 4Sept 2020Series A, Seed
Investor 5Sept 2020Series A, Seed
Investor 6Sept 2020Series A, Seed

Share Capital

Share Capital

Share allotments and capital structure

20 Allotments 70,717,064 Shares £71.41m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
25 Feb 202687,840£0.878£0
21 Nov 2025483,499£4.835£0
14 Aug 202533,136£0.331£0
14 Aug 202533,136£0.331£0
18 Jun 20258,479£0.085£0

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (51)

New Enterprise Associates 17, L.p
18.8%
16,858,521
Astellas Gene Therapies Inc
11.1%
9,960,409

Persons with Significant Control

Persons with Significant Control (0)

0 Active 6 Ceased

Advent Life Sciences Llp

Ceased 3 Dec 2021

Ceased

Kings College London

Ceased 3 Dec 2021

Ceased

Christopher Edward Dennistoun Shaw

Ceased 11 Sept 2020

Ceased

Johnson & Johnson

Ceased 3 Dec 2021

Ceased
Ceased

Lifearc

Ceased 3 Dec 2021

Ceased

Group Structure

Group Structure

AVIADOBIO LTD Current Company
NEUROGENEUS LTD united kingdom

Charges

Charges

1 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Apr 2026CapitalAllotment of shares (GBP 911.57365) on 2026-04-16
8 Apr 2026CapitalAllotment of shares (GBP 909.64804) on 2026-04-01
1 Apr 2026OfficersAppointment of Julio Cesar Lopez as director on 2026-03-20
1 Apr 2026OfficersTermination of Matthew Douglas Mcaviney as director on 2026-03-20
25 Feb 2026CapitalAllotment of shares (GBP 897.6828) on 2026-02-25
21 Apr 2026 Capital

Allotment of shares (GBP 911.57365) on 2026-04-16

8 Apr 2026 Capital

Allotment of shares (GBP 909.64804) on 2026-04-01

1 Apr 2026 Officers

Appointment of Julio Cesar Lopez as director on 2026-03-20

1 Apr 2026 Officers

Termination of Matthew Douglas Mcaviney as director on 2026-03-20

25 Feb 2026 Capital

Allotment of shares (GBP 897.6828) on 2026-02-25

Recent Activity

Latest Activity

Allotment of shares (GBP 911.57365) on 2026-04-16

1 days ago on 21 Apr 2026

Allotment of shares (GBP 909.64804) on 2026-04-01

2 weeks ago on 8 Apr 2026

Appointment of Julio Cesar Lopez as director on 2026-03-20

3 weeks ago on 1 Apr 2026

Termination of Matthew Douglas Mcaviney as director on 2026-03-20

3 weeks ago on 1 Apr 2026

Allotment of shares (GBP 897.6828) on 2026-02-25

1 months ago on 25 Feb 2026